PreveCeutical Showcases Dynamic Evolution in AI Strategy
VANCOUVER, BC, Sept. 12, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an important chapter in the journey of PreveCeutical Medical Inc., a pioneering figure in the realm of medical technology.
- VANCOUVER, BC, Sept. 12, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an important chapter in the journey of PreveCeutical Medical Inc., a pioneering figure in the realm of medical technology.
- The Company unveils a comprehensive narrative around its growing involvement and innovation in the vast domain of Artificial Intelligence (AI).
- Central to PreveCeutical's AI strategy is its aspiration to harness vast repositories of specialized data, driving the next wave of medical insights and innovations.
- Stephen Van Deventer, the CEO of PreveCeutical Medical Inc., commented, "Today's AI narrative isn't just an update; it's a testament to our unwavering commitment to driving innovation.